Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Endurant CHevAr New Indication Trial: ENCHANT

NCT: NCT03320252 · ACTIVE_NOT_RECRUITING

NCT IDNCT03320252
StatusACTIVE_NOT_RECRUITING
Start Date2017-10-26
SponsorMedtronic Cardiovascular (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of the post-market study is to assess the clinical outcomes, safety, and performance of the Endurant Chimney Graft Technique (Endurant Stent Graft Systems used with a balloon-expandable covered stent graft) for treatment of juxtarenal aortic aneurysms with a short infrarenal neck in a real world setting.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑